Sunday, 15 November 2026 Clear skyNew Delhi 21° New DelhiLondonNew YorkDubaiTokyo
INDEPENDENT THINKING.
SHARED UNDERSTANDING.International edition · Correspondents across India and around the world
RationalTimes●
A little less noise.
A little more perspective. Join our media house
BREAKING
VerifiedSoutheast Asian Leaders Open Annual Summit Amid Major Global Conflicts VerifiedUS FDA Rejects Summit's China-Originated Lung Cancer Drug VerifiedICC locks in dates for major men's tournaments from 2028 to 2035 VerifiedCricket Coverage Banned On Kandahar Radio Under New Taliban Directive: Report VerifiedSonakshi Sinha's Morphed Photos Case: Accused Released By Mumbai Court ClimateCOP31 climate talks open in Antalya, Türkiye, on 9 November USAmericans vote in the midterm elections on 3 November TechnologyNorth Korea-linked hackers steal about $6.4 billion from Binance in the biggest crypto theft on record, analysts say WorldSpain mourns after a high-speed train ploughs into a stationary train near Toledo, killing at least 68 WorldIsrael’s election ends without a clear winner as exit polls leave both blocs short of a majority WorldSaudi Arabia intercepts Houthi missiles and drones as Egypt’s parliament backs military support PoliticsLula wins Brazil’s presidential runoff as Flávio Bolsonaro concedes
Verified · 2 outletsIndia

US FDA Rejects Summit's China-Originated Lung Cancer Drug

Headline via NDTV · first report 15 Nov, 20:18 IST, latest 15 Nov, 20:35 IST

The US Capitol, Washington
Representational image · The US Capitol, Washington · Martin Falbisoner / Wikimedia Commons, CC BY-SA 3.0

What we know

2 independent news organisations have reported this story. The first report we saw came from NDTV at 15 Nov, 20:18 IST; the latest is from STAT at 15 Nov, 20:35 IST. Rational Times has not independently confirmed the details: read each report through the links below.

StatusVerified
Reported by2 news organisations
First report15 Nov, 20:18 IST
Latest report15 Nov, 20:35 IST
DeskIndia

What the reports sayEach newsroom’s own summary of its report, from its feed

The FDA issued a so-called Complete Response Letter saying that it can't approve Summit's application in its present form because the drug didn't help patients live longer in a statistically...
The FDA has rejected ivonescimab, a treatment for a type of lung cancer developed by U.S. biotech Summit Therapeutics and the Chinese drugmaker Akeso.

Quoted from the newsrooms’ own feeds, with their names and links. Rational Times has not independently confirmed the details.

About China India United StatesAsiaNorth AmericaHealth 15 Nov 2026

The reports2 reports

Headlines belong to the news organisations named; each links to their own report. We group reports automatically by their key words, so now and then two different stories can be grouped together, or one story split in two. Tell us about a mistake

Read nextThe biggest stories right now